Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front Med    2011, Vol. 5 Issue (3) : 315-320     DOI: 10.1007/s11684-011-0146-6
Translating evidence into policy in China: opportunities and challenges
Jiyao Wang1,3(), Xuejuan Jin2,3
1. Department of Internal Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China; 2. Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China; 3. Center of Clinical Epidemiology and Evidence-based Medicine, Fudan University, Shanghai 200032, China
Download: PDF(121 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Research and evidence are critical for the formulation of policies and practices in support of health care. In the past two decades, the Chinese Clinical Epidemiology Network has been promoting evidence-based policy making in China. Evidence-based policy has become a major part of the government’s approach to policy making. The current article addresses the translation of evidence into health policies based on the expansion of evidence-based medicine in China. It also discusses the opportunities and challenges for certain evidence to be considered in policy making and practice in the future.

Keywords clinical epidemiology      evidence-based decision making      policy     
Corresponding Authors: Wang Jiyao,   
Issue Date: 05 September 2011
URL:     OR
Regional Clinical Epidemiology Resource and Training Centers
– Fudan University
– Sichuan University
Clinical Epidemiology Units
– Peking Union Medical College
– Fourth Military Medical University
– Central South University
– China Academy of Traditional Chinese Medicine
– Zhejiang University
– Shanghai Jiao Tong University School of Medicine
– Shandong University
– Beijing University of Chinese Medicine
– Second Military Medical University
Tab.1  Chinese Clinical Epidemiology Network (ChinaCLEN)
Fig.1  Chinese medicine clinical research platform.
Fig.2  A new paradigm for the 21st century.
Fig.3  Evidence sources and knowledge management.
1 Wang J. Evidence-based medicine. Chin J Intern Med (Zhonghua Nei Ke Za Zhi) 2000; 39(4): 279–280 (in Chinese)
2 Wang J. Evidence-based medicine in China. Lancet 2010; 375(9714): 532–533
doi: 10.1016/S0140-6736(09)62131-0 pmid:20159275
3 The Lancet. Reforming research in China. Lancet 2007; 369(9565): 880
doi: 10.1016/S0140-6736(07)60419-X pmid:17368128
4 Guo L. China boosts medical research. Lancet 2010; 375(9716): 711
doi: 10.1016/S0140-6736(10)60288-7 pmid:20201132
5 Guan N, Fan Q, Ding J, Zhao Y, Lu J, Ai Y, Xu G, Zhu S, Yao C, Jiang L, Miao J, Zhang H, Zhao D, Liu X, Yao Y. Melamine-contaminated powdered formula and urolithiasis in young children. N Engl J Med 2009; 360(11): 1067–1074
doi: 10.1056/NEJMoa0809550 pmid:19196669
6 Bian Z, Liu B, Moher D, Wu T, Li Y, Shang H, Cheng C. Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development. Front Med 2011; 5(2): 171–177
doi: 10.1007/s11684-011-0132-z pmid:21695622
7 Wang SC, Liu JP, Li H, Yu H. Guidelines for evidence-based Chinese medicine clinical pathway report. J Chin Integr Med (Zhong Xi Yi Jie He Xue Bao) 2010; 8(9): 819–823 (in Chinese)
doi: 10.3736/jcim20100903 pmid:20836970
8 Zhou X, Chen S, Liu B, Zhang R, Wang Y, Li P, Guo Y, Zhang H, Gao Z, Yan X. Development of traditional Chinese medicine clinical data warehouse for medical knowledge discovery and decision support. Artif Intell Med 2010; 48(2-3): 139–152
doi: 10.1016/j.artmed.2009.07.012 pmid:20122820
9 Wang Y, Liu B, Xie Y. Establishing appraisal mechanism of clinic studies in traditional Chinese medicine with proofing medicine methodology. Chin J Basic Med Tradit Chin Med (Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi) 2003; 9(3): 17–23 (in Chinese)
10 Liu B, Zhang Y, Hu J, He L, Zhou X. Thinking and practice of accelerating transformation of traditional Chinese medicine from experience medicine to evidence-based medicine. Front Med 2011; 5(2):163–170
doi: 10.1007/s11684-011-0143-9 pmid:21695621
11 Wang N. Current status of evidence-informed health decision-making and the establishment of priority issue in the evidence-informed health decision-making network. Dissertation for Master’s Degree . Ji’nan: Shandong University, 2007 (in Chinese)
12 Wang J, Gluud C. Evidence-based Medicine and Clinical Practice. 2nd . Beijing: Science Press. 2006 (in Chinese)
13 Wang Y, Wang CM. Diagnosis and treatment guidelines for acute fever of unknown etiology in Chinese children aged 0 to 5. Chin J Evid Based Pediatr (Zhongguo Xun Zheng Er Ke Za Zhi) 2008; 11(3): 449–457 (in Chinese)
14 Wang J. Correct the misconceptions about evidence-base medicine. Natl Med J China (Zhonghua Yi Xue Za Zhi) 2004; 84(12): 969–970 (in Chinese)
15 Wu T, Li Y, Bian Z, Liu G, Moher D. Randomized trials published in some Chinese journals: how many are randomized? Trials 2009; 10(1): 46
doi: 10.1186/1745-6215-10-46 pmid:19573242
16 Hutchinson E, Droti B, Gibb D, Chishinga N, Hoskins S, Phiri S, Parkhurst J. Translating evidence into policy in low-income countries: lessons from co-trimoxazole preventive therapy. Bull World Health Organ 2011; 89(4): 312–316
doi: 10.2471/BLT.10.077743 pmid:21479096
17 Aldridge RW, Cole KJ, Hurst L, McKee M, Horton R. Lancet UK policy matters: better evidence for better health. Lancet 2011; 377(9778): 1631–1633
doi: 10.1016/S0140-6736(11)60652-1 pmid:21571133
[1] Chunsong Hu,Qinghua Wu. Health: a dream from reality to the future[J]. Front. Med., 2016, 10(2): 233-235.
[2] Douglas Sipp. The unregulated commercialization of stem cell treatments: a global perspective[J]. Front Med, 2011, 5(4): 348-355.
Full text